“Hard to Reach” Is a Sponsor Operations Failure, Not a Population Problem
The Lancet calls out "hard to reach" as a stigmatizing label. For clinical ops, it's a site selection failure...
Another AI Clinical Data Platform Just Launched. Here’s What Sponsors Actually Need to Ask Before They Sign.
nPhase's AI clinical data platform promises smarter trial design, but before sponsors add another vendor, the activation-cycle math deserves...
A 25% Sample Size Cut Sounds Like a Win, Until You See the Amendment Queue
CONSONANCE's digitally enhanced MS endpoint cut required sample size 24.9%. Here's what that number costs in protocol amendments, IRB...
Fortrea’s $45M Phase I Grab Is Your Vendor Continuity Problem Now
Fortrea's $45M acquisition of Worldwide Clinical Trials' early-phase division reshapes Phase I site networks and vendor contracts for sponsors...
Fortrea’s $45M Early Phase Deal Sets a 90-Day Test for Sponsors With Active Studies
Fortrea's $45M buy of Worldwide Clinical Trials' Early Phase Services unit means active sponsors face contract novation, lab method...
Stop Writing ‘Routine Labs.’ Every Lab Line Needs Its Own Coverage Citation
A CBC isn't covered because it's routine. It's covered because NCD 190.15 says when. Here's how citation-level MCAs survive...
When Early Efficacy Data Forces a Site Ramp You Weren’t Budgeted For
Aprea's APR-1051 early signals are forcing a rapid site expansion—here's what the enrollment acceleration actually costs at the operational...
When the Sponsor’s IT Goes Down, Your Trial Goes With It
Boston Scientific's August 2026 cyberattack knocked out global IT and shipping. Here's what that means for sites running active...
When a Sponsor Switches Technology Platforms, the Site Feels It First
A sponsor's mid-study clinical system migration lands on sites first: reconciliation work, documentation risk, and monitoring gaps nobody budgeted....
What Merck and SCRI’s Community Network Deal Actually Means for Site Operations
Merck and SCRI's Accelero™ collaboration targets community oncology enrollment, but the real test is whether 200+ sites can execute...